Skip to main content
NCBI home page
Gut logoLink to Gut
. 1989 Jan;30(1):110–117. doi: 10.1136/gut.30.1.110

Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.

S J Konturek 1, J Tasler 1, J W Konturek 1, M Cieszkowski 1, K Szewczyk 1, M Hładij 1, P S Anderson 1
PMCID: PMC1378240  PMID: 2920915

Abstract

Postprandial pancreatic secretion results from the interaction of neural and hormonal factors but their contribution to the net postprandial secretion is unknown. Recent description of highly specific and potent cholecystokinin (CCK) receptor antagonists allows the determination of the physiological role of CCK in the postprandial pancreatic secretion. In six dogs with chronic pancreatic fistulae, the blockade of CCK receptors by non-peptidal agent (L-364,718) caused little change in basal pancreatic secretion, but decreased significantly (p less than 0.05) by about 60% the pancreatic protein response to meat feeding and virtually abolished the pancreatic responses to CCK-8 and bombesin. The pancreatic protein responses to pentagastrin, reaching about 37% of CCK maximum, was also significantly reduced but this effect was less pronounced than that observed in tests with CCK-8 or bombesin stimulation. In contrast, cholinergically stimulated pancreatic secretion, reaching about 40% of CCK maximum, was unaffected by L-364,718. Cholecystokinin antagonism also failed to affect the postprandial and bombesin induced increments in plasma CCK and gastrin concentrations, but significantly reduced the PP responses to CCK-8 bombesin and meat feeding possibly as a result of the removal of the CCK mediated release of PP. We conclude that CCK plays a crucial role in the mediation of the postprandial and bombesin induced pancreatic secretion and in the PP release.

Full text

PDF
110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Byrnes D. J., Henderson L., Borody T., Rehfeld J. F. Radioimmunoassay of cholecystokinin in human plasma. Clin Chim Acta. 1981 Mar 19;111(1):81–89. doi: 10.1016/0009-8981(81)90424-1. [DOI] [PubMed] [Google Scholar]
  2. Chang R. S., Lotti V. J. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4923–4926. doi: 10.1073/pnas.83.13.4923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Debas H. T., Konturek S. J., Grossman M. I. Effect of extragastric and truncal vagotomy on pancreatic secretion in the dog. Am J Physiol. 1975 Apr;228(4):1172–1177. doi: 10.1152/ajplegacy.1975.228.4.1172. [DOI] [PubMed] [Google Scholar]
  4. Debas H. T., Yamagishi T. Evidence for pyloropancreatic reflux for pancreatic exocrine secretion. Am J Physiol. 1978 May;234(5):E468–E471. doi: 10.1152/ajpendo.1978.234.5.E468. [DOI] [PubMed] [Google Scholar]
  5. Jensen R. T., Zhou Z. C., Murphy R. B., Jones S. W., Setnikar I., Rovati L. A., Gardner J. D. Structural features of various proglumide-related cholecystokinin receptor antagonists. Am J Physiol. 1986 Dec;251(6 Pt 1):G839–G846. doi: 10.1152/ajpgi.1986.251.6.G839. [DOI] [PubMed] [Google Scholar]
  6. Konturek S. J. Current concepts of neuro-hormonal control of pancreatic secretion. Ir J Med Sci. 1978 Jan;147(1):1–10. doi: 10.1007/BF02939360. [DOI] [PubMed] [Google Scholar]
  7. Konturek S. J., Konturek J. W., Lamers C. B., Tasler J., Bilski J. Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin. Int J Pancreatol. 1987 Aug;2(4):223–235. doi: 10.1007/BF02788400. [DOI] [PubMed] [Google Scholar]
  8. Konturek S. J., Tasler J., Bilski J., de Jong A. J., Jansen J. B., Lamers C. B. Physiological role and localization of cholecystokinin release in dogs. Am J Physiol. 1986 Apr;250(4 Pt 1):G391–G397. doi: 10.1152/ajpgi.1986.250.4.G391. [DOI] [PubMed] [Google Scholar]
  9. Liddle R. A., Goldfine I. D., Rosen M. S., Taplitz R. A., Williams J. A. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest. 1985 Apr;75(4):1144–1152. doi: 10.1172/JCI111809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lotti V. J., Pendleton R. G., Gould R. J., Hanson H. M., Chang R. S., Clineschmidt B. V. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther. 1987 Apr;241(1):103–109. [PubMed] [Google Scholar]
  11. Pendleton R. G., Bendesky R. J., Schaffer L., Nolan T. E., Gould R. J., Clineschmidt B. V. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist. J Pharmacol Exp Ther. 1987 Apr;241(1):110–116. [PubMed] [Google Scholar]
  12. Preshaw R. M., Cooke A. R., Grossman M. I. Stimulation of pancreatic secretion by a humoral agent from the pyloric gland area of the stomach. Gastroenterology. 1965 Dec;49(6):617–622. [PubMed] [Google Scholar]
  13. Rovati A. L., Casula P. L., Da Re G. Attività antisecretiva di alcuni nuovi composti PRIVI DI ATTIVIT-A ANTICOLINERGICA. Minerva Med. 1967 Oct 27;58(86):3651–3653. [PubMed] [Google Scholar]
  14. Singer M. V. Latency of pancreatic fluid secretory response to intestinal stimulants in the dog. J Physiol. 1983 Jun;339:75–85. doi: 10.1113/jphysiol.1983.sp014703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Soll A. H., Amirian D. A., Park J., Elashoff J. D., Yamada T. Cholecystokinin potently releases somatostatin from canine fundic mucosal cells in short-term culture. Am J Physiol. 1985 May;248(5 Pt 1):G569–G573. doi: 10.1152/ajpgi.1985.248.5.G569. [DOI] [PubMed] [Google Scholar]
  16. Solomon T. E., Grossman M. I. Effect of atropine and vagotomy on response of transplanted pancreas. Am J Physiol. 1979 Feb;236(2):E186–E190. doi: 10.1152/ajpendo.1979.236.2.E186. [DOI] [PubMed] [Google Scholar]
  17. Solomon T. E. Regulation of pancreatic secretion. Clin Gastroenterol. 1984 Sep;13(3):657–678. [PubMed] [Google Scholar]
  18. Stubbs R. S., Stabile B. E. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat. Am J Physiol. 1985 Mar;248(3 Pt 1):G347–G352. doi: 10.1152/ajpgi.1985.248.3.G347. [DOI] [PubMed] [Google Scholar]
  19. Swierczek J. S., Konturek S. J., Tasler J., Jaworek J., Cieszkowski M. Pancreatic polypeptide and vagal stimulation of gastric and pancreatic secretion in dogs. Hepatogastroenterology. 1981 Aug;28(4):206–209. [PubMed] [Google Scholar]
  20. THOMAS J. E. MECHANISM OF ACTION OF PANCREATIC STIMULI STUDIED BY MEANS OF ATROPINELIKE DRUGS. Am J Physiol. 1964 Jan;206:124–128. doi: 10.1152/ajplegacy.1964.206.1.124. [DOI] [PubMed] [Google Scholar]
  21. WHITE T. T., LUNDH G., MAGEE D. F. Evidence for the existence of a gastropancreatic reflex. Am J Physiol. 1960 Apr;198:725–728. doi: 10.1152/ajplegacy.1960.198.4.725. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES